• Medtronic announces FDA approval of spinal cord stimulation platform

    7 days ago - By Healio

    Medtronic plc has announced FDA approval of the Vanta neurostimulator, an implantable spinal cord stimulation device with up to 11 years of recharge-free battery life, according to a press release.
    The Vanta device uses a built-in accelerometer to provide patients with a personalized pain relief option. The device also allows for full-body MRI access with Medtronic's SureScan technology, according to the release.
    “We are committed to delivering innovative solutions that meets the needs of every patient,” Charlie Covert, vice president and general manager of pain therapies at
    Read more ...